✦ LIBER ✦

PDB26 Projected Long-Term Clinical and Economic Outcomes of Exenatide Once Weekly Versus Sitagliptin for the Treatment of Type 2 Diabetes in the UK

✍ Scribed by Beaudet, A.; Wilson, B.; Caputo, J.; Timlin, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB9 LONG-TERM CLINICAL OUTCOMES OF EXEN

✍ L Timlin; A Beaudet; B Wilson; D Bruhn; KS Boye; JL Palmer; A Lloyd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB27 Projected Cost-Effectiveness of Ex

✍ Wilson, B.P.; Beaudet, A.; Caputo, J.; Timlin, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PDB36 LONG-TERM COST-CONSEQUENCE ANALYSI

✍ Gaebler J Aledort; Y Samyshkin; ALG Guillermin; A Lloyd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB27 COST-EFFECTIVENESS OF EXENATIDE VE

✍ D Bruhn; S Malhan; S Kavuncubasi; J Smith-Palmer; V Reed 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Exenatide once weekly for the treatment

✍ R. Pencek; A. Blickensderfer; Y. Li; S. C. Brunell; S. Chen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

Efficacy and safety of exenatide once we

✍ Richard M Bergenstal; Carol Wysham; Leigh MacConell; Jaret Malloy; Brandon Walsh 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 399 KB